Eye Symptoms in a Patient With Prostate Cancer

A 66-year-old man with castration-resistant prostate cancer was evaluated with 18F–prostate-specific membrane antigen (PSMA) 1007 PET/CT, which revealed extensive PSMA-positive skeletal metastases in the skull, thorax, spine, pelvis, and extremities. He was then treated 177Lu-PSMA-617 therapy. Twenty-four-hour SPECT/CT revealed additional activity not seen with 18F-PSMA adjacent to his left eye. The lesion was biopsied after the first cycle due to pain. This activity was not visible on SPECT/CT after the second treatment cycle, and his eye pain has resolved.
Source: Clinical Nuclear Medicine - Category: Nuclear Medicine Tags: Interesting Images Source Type: research